A Study of Alisertib and Paclitaxel in Patients With Small Cell Lung Cancer (SCLC)

NCT07465757 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Cell Lung Cancer ( SCLC )

Interventions

DRUG: Alisertib
DRUG: Alisertib
DRUG: Alisertib
DRUG: Alisertib
DRUG: Alisertib
DRUG: Paclitaxel

Sponsor

Puma Biotechnology, Inc.